Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Neutralase effective for heparin reversal in CAB

May 27, 1997

Texas Biotechnology reports phase III results with Novastan in HIT and HITTS

May 23, 1997

Molecumetics and Asahi enter anticoagulant collaboration

May 22, 1997

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Searle describes antiplatelet agents

May 20, 1997

3-D describes potent and selective thrombin inhibitors

May 15, 1997

Factor Xa inhibitors from 3-D

May 15, 1997

Fibrinogen antagonists reported by Lilly/Cor Therapeutics

May 14, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...